• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Issue Issue 1
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
El-Samrah, M., Swelem, M., Mohammed, K. (2025). CANCER ANTIGEN -125 IN THE DETERMINATION OF SEVERITY IN CASES OF SEVERE PRE-ECLAMPSIA.. ALEXMED ePosters, 7(1), 39-40. doi: 10.21608/alexpo.2025.360099.2093
Mohamed El-Samrah; Manal Shafik Swelem; Kaltume Mohammed. "CANCER ANTIGEN -125 IN THE DETERMINATION OF SEVERITY IN CASES OF SEVERE PRE-ECLAMPSIA.". ALEXMED ePosters, 7, 1, 2025, 39-40. doi: 10.21608/alexpo.2025.360099.2093
El-Samrah, M., Swelem, M., Mohammed, K. (2025). 'CANCER ANTIGEN -125 IN THE DETERMINATION OF SEVERITY IN CASES OF SEVERE PRE-ECLAMPSIA.', ALEXMED ePosters, 7(1), pp. 39-40. doi: 10.21608/alexpo.2025.360099.2093
El-Samrah, M., Swelem, M., Mohammed, K. CANCER ANTIGEN -125 IN THE DETERMINATION OF SEVERITY IN CASES OF SEVERE PRE-ECLAMPSIA.. ALEXMED ePosters, 2025; 7(1): 39-40. doi: 10.21608/alexpo.2025.360099.2093

CANCER ANTIGEN -125 IN THE DETERMINATION OF SEVERITY IN CASES OF SEVERE PRE-ECLAMPSIA.

Article 1, Volume 7, Issue 1, January 2025, Page 39-40  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2025.360099.2093
View on SCiNiTO View on SCiNiTO
Authors
Mohamed El-Samrah; Manal Shafik Swelem; Kaltume Mohammed email
Department; Obstetrics and Gyanacology Alexandra University Egypt.
Abstract
Pre-eclampsia is defined as hypertension that appears after 20 weeks of gestation, in addition to proteinuria or other indicators of injury to end organ damage during pregnancy , is a significant contributor to maternal and perinatal death and morbidity especially when it manifests early.
Epidemeology.
A pregnancy specific illness ,pre-eclampsia affects 3-5 % of expectant mothers ,high blood pressure, proteinuria and edema are one of its characteristics.
Categorization of hypertensive disorders associated with pregnancy .
1. Pre-eclampsia.
2. Gestational hypertension.
3. Super imposed pre-eclampsia.
4. Chronic hypertension.
Potential causes of pre-eclampsia.
1. Advanced maternal age.
2.Obesity.
3. Nulliparity.
4. Multi fetal pregnancy.
5. Family history of pre-eclampsia.
6. Previous history of pre-eclampsia
COMPLICATIONS OF PRE-ECLAMPSIA.
Maternal complications.
1. Eclampsia.
2. HELLP SYNDROME.
3. Cardiovascular complications.
4. Renal complications.
5. Neurological complications.
Fetal complications.
1. fetal growth restriction.
2. Premarturity.

AIM OF THE WORK.
The aim of these study is to analyze the association of CA-125 values as an affordable and widely available , and establish its potential role in evaluation of pre-eclampsia severity.
Keywords
CANCER ANTIGEN; PRE-ECLAMPSIA; SEVERE
Supplementary Files
download 2093 KALTUME MOHAMMED.pdf
Statistics
Article View: 24
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.